Savoirs
Treatment outcome and prognostic factor analysis in transplant-eligible Chinese myeloma patients receiving bortezomib-based induction regimens including the staged approach, PAD or VTD
Chim Chor, Lie, Lau Ching, Yip Sze, Sim Joycelyn, Wan Thomas, Ma Edmond, Liang Raymond, Tse Eric, Kwong Yok-Lam, Liu, Chan, For